Free Trial

Moleculin Biotech (MBRX) SEC Filings & 10K Form

Moleculin Biotech logo
$2.45
-0.15 (-5.77%)
(As of 11/1/2024 ET)

Recent Moleculin Biotech SEC Filings

DateFilerForm TypeView
10/25/2024
3:43 PM
Moleculin Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/25/2024
3:16 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:40 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
7:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
4:15 PM
Moleculin Biotech (Filer)
Form PRE 14A
08/19/2024
3:10 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
9:06 AM
Moleculin Biotech (Filer)
Form 424B3
08/16/2024
3:54 PM
Moleculin Biotech (Filer)
Form 424B4
08/15/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
08/15/2024
10:21 AM
Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
8:57 PM
Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
7:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
8:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:35 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:00 AM
Moleculin Biotech (Filer)
Form S-1/A
07/22/2024
4:31 PM
Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/10/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
4:01 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
06/25/2024
5:00 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:01 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:02 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:00 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:01 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:01 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
7:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:05 PM
Moleculin Biotech (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/16/2024
7:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:38 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:16 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:55 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
8:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM
Moleculin Biotech (Filer)
Form 10-K/A
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

04/25/2024
7:23 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
4:14 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
8:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
2:03 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
3:31 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
8:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
4:19 PM
Moleculin Biotech (Filer)
Form 424B3
02/15/2024
8:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:36 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:43 PM
ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
Form SC 13G
02/12/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
02/02/2024
4:05 PM
Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/24/2024
7:50 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
4:14 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
4:15 PM
Moleculin Biotech (Filer)
Form PRE 14A
12/27/2023
6:31 AM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
6:31 AM
George Robert E. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
6:32 AM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:00 PM
Moleculin Biotech (Filer)
Form 424B5
12/21/2023
4:17 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
7:55 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
7:55 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
7:50 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
8:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:00 AM
Moleculin Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
7:45 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
7:35 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MBRX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners